We are thrilled to have Joyce join our team. With her vast experience she will bring us to a new level of proficiency in our Flow Cytometry practices and will allow us to expand the range of services we offer to our current and potential clients.
Shawnee, KS / Kansas City, MO (PRWEB) April 05, 2016
KCAS Bioanalytical and Biomarker Services, a small and large molecule Good Laboratory Practices (GLP) and Good Clinical Practices (GCP)-compliant and certified registrant for Clinical Laboratory Improvement Amendments (CLIA) bioanalytical and biomarker contract research organization (CRO) has welcomed Joyce Slusser as Senior Scientist in their large molecule department.
With more than 16 years experience with Flow Cytometry and 6 years of experience in various CLIA environments Dr. Slusser will be instrumental in the continuing development and expansion of services offered within KCAS’s large molecule department.
For most of her career Joyce has focused her passion on biomarker discovery for drug action and immune monitoring in disease/treatment through Flow Cytometry. Dr. Slusser is an active member of multiple Cytometry associations and is the founder of Great Plains Analytical Cytometry Association. Before coming to KCAS she was a global senior application market analyst for Beckman Coulter. Joyce also was a research assistant professor at the University of Kansas Medical Center.
“We are thrilled to have Joyce join our team. With her vast experience she will bring us to a new level of proficiency in our Flow Cytometry practices and will allow us to expand the range of services we offer to our current and potential clients,” said Michael Lanman, acting CEO and Vice President of Operations. “We are excited to see what her contributions and regulatory insight brings to this role at KCAS, and expect her energy and effort to further enhance the expertise of services provided by KCAS."
About KCAS Bioanalytical Services
KCAS Bioanalytical & Biomarker Services is a contract research organization (CRO) with 36+ years of bioanalytical expertise. We specialize in the development and validation of robust small molecule, large molecule and biomarker methods for discovery, preclinical and clinical studies. Our dedicated scientific and laboratory teams have an average tenure of 14 years, and have developed and validated more than 5,500 bioanalytical assays. Learn more at: http://www.kcasbio.com